Declan Murphy retweeted
When "cancer" is a diagnosis but not really a disease
A slightly more philosophical piece than my usual—on what we mean by cancer, and whether the word itself can sometimes do more harm than good.... let me know what you think!
Many thanks @pam3001 @aeonmag
aeon.co/essays/we-need-a-bet…
Declan Murphy retweeted
Great few days at the Irish Society of Urology meeting in Killarney. @RenuEapen and @declangmurphy loved the hospitality and scientific exchange. A GU Cast Live Event and conference highlights to come @RCSI_Irl
Declan Murphy retweeted
Spectacular #livesurgery at the @Uroweb ERUS Meeting in Padua. #robotic #surgery #telesurgery. @declangmurphy @RenuEapen and GU Cast bringing you highlights @ERUSrobotics @AlbertoBreda1 – at Padua, Veneto
Declan Murphy retweeted
In a 10-yr follow-up of a randomized trial, Retzius-sparing RARP (better early continence) showed worse long-term cancer control than the anterior approach — 2.64x higher progression risk after adjustment. Post-hoc, hypothesis-generating. free link:authors.elsevier.com/a/1njm6…
Sigh. That sinking feeling when you know the monopolar shears is on its last life 😭#safetyscissors #roboticsurgery
Declan Murphy retweeted
GU Cast tackles “randomised trials that did not change practice”! Kidney cancer and robotic prostatectomy. With our Journal Club Editors @elena_k_berg @carlosdelgadord and Hosts @RenuEapen @declangmurphy youtu.be/aRi6ZQH2egY?si=8WQt…
Declan Murphy retweeted
Replying to @AshTewariMD
@AshTewariMD joins GU Cast to talk all things nerve-sparing #roboticprostatectomy. And cricket! Fascinating 20yr journey to get to his technique today. Includes surgical footage #prostatecancer @MountsinaiUro @RenuEapen @declangmurphy youtu.be/kuC7uHRZzT4?si=PNZO…
Declan Murphy retweeted
🎤Our very own @mroupret & @Ric_Campi chats with @declangmurphy and @RenuEapan, hosts of @gu_onc and its spin off, European Urology Podcast.
buff.ly/oyf9TzG or listen wherever you find your podasts
Watch on You Tube: buff.ly/qZPZ7dk
📢Papers highlighted in this podcast include:
🩺Expanding Risk-adapted Early Detection of Prostate Cancer: A Call to Action for Men at High Risk by Maike K. Klett...Alicia K. Morgans et al
buff.ly/GKHLmIF
🩺Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical Perspective by Igor Duquesne...François Audenet et al
buff.ly/W6qEsXb
🩺Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility Study by Chiara Re...Grant D. Stewart et al
buff.ly/3POVmI6
🩺Improved Shared Decision-making for Patients with Renal Cell Carcinoma: Results of the SDM-RCC Study by Cato C. Bresser...Paul B. van der Nat et al (for the SDM-RCC Study Group)
buff.ly/43Jcevo
@uroweb
@GPloussard
@jteoh_hk
@CaPsurvivorship
@LauraMarandino
@Ecastromarcos
@OncoAlert
@Sciencedirect
Enjoy!
Declan Murphy retweeted
UAA 2026 in Manila, Philippines! Come join the congress for tips/tricks, updates and the famous hospitality that the Filipinos are known for. It’s going to be a great meeting!
Declan Murphy retweeted
We warmly invite you to join @OncoAlert 🚨 in Lugano, Switzerland🇨🇭 , from April 29 to May 1, 2027, for #LPCCC27 — the Localized Prostate Cancer Consensus Conference.
👉 buff.ly/rgNSNqI
🔗 Register now and be part of #LPCCC27 in Lugano!
Building on the success and trusted format of APCCC, LPCCC will bring together leading international experts, clinicians, researchers, and patient advocates every other year to address the most important challenges in the diagnosis and clinical management of localized #ProstateCancer
📅 Register early and save!
Take advantage of early-bird rates and exclusive discounts for students, nurses, charity representatives, and participants from LICs and LMICs attending in person.
🌐 Free registration is available for patient representatives, press representatives, and online participants from LICs and LMICs.
Join the global forum shaping the future of localized prostate cancer care!
#ProstateCancer #GUOncology #UroOnc #CancerCare #PrecisionMedicine #Oncology
@Silke_Gillessen
@ProfKHerrmann
@LoebStacy
@declangmurphy
@DrSpratticus
@Tilki_De
@piet_ost
@alison_tree
@AOmlin
@ResearchWyatt
@ckcding
@stefanofanti4
Ping
@nataliagandur
@scocmem
@AmandaNizamMD
Declan Murphy retweeted
A great conversation about ABC of Nerve Sparing robotic prostatectomy with Mr. Declan Murphy and Dr. Rene Eapen. Thanks Declan and Renu for your podcast. youtu.be/kuC7uHRZzT4
Thanks so much @NehaVapiwala for inviting me to dial into this great @ASTRO_org webinar with @AmarUKishan. I learned a lot! Great to talk multidisciplinary approaches to high-risk prostate cancer
7.15am here, patient should be going to sleep. But World Cup final just went to extra time. “Will my prostate cancer deteriorate if we delay 45 min? No” Come on Spain!
Declan Murphy retweeted
Replying to @Uromigos
Happy 500th Episode!! @gu_onc salutes you @brian_rini @tompowles1 @RenuEapen @declangmurphy #podcast🎙️🥂
Declan Murphy retweeted
Happy 4th of July! 🇺🇸
Rounding in hospital today in my cool @gu_onc tee. (Thanks @RenuEapen @declangmurphy )
Wishing everyone a safe, happy, and healthy Independence Day.
@CleClinicMD
Quick jump from deep Winter in Melbourne to the hottest day on record in Berlin! Great place to record a GU Cast with old friends @BertrandTOMBAL @SFreedlandMD @gu_onc Coming soon
Declan Murphy retweeted
🎙️ The June 2026 European Urology Podcast is here!
Join hosts @declangmurphy and @RenuEapen as they speak with Editor-in-Chief @Albert0Briganti, who highlights three Editor's Choice papers from the June issue and shares his reaction to the newly released Impact Factors. 📈
Editor's Choice papers:
1️⃣ Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee
lnkd.in/eqfUyuVr
2️⃣ Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group
lnkd.in/e5U7zWtU
🎧 Full GU Cast episode: lnkd.in/eEcCT_WZ
3️⃣ Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium [68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial)
lnkd.in/ewb2atSj
🎧 Full GU Cast episode: lnkd.in/eX9JfxrP
📚 Explore the full June 2026 issue:
lnkd.in/eciKPEBM
🎧 Also available as an audio podcast—search European Urology Podcast wherever you get your podcasts.
The European Urology Podcast is produced by the GU Cast team in Melbourne, Australia.
International guests in GU Cast studio already this week:
Tuesday night - @shilpaonc
Wednesday night - @DrRanaMcKay
Two of our all-time favourite GU medical oncologists!
Coming soon on GU Cast! @RenuEapen @gu_onc
Declan Murphy retweeted
🏆 European Urology remains at the top of our field in Nephrology and Urology!
📈 With our Impact Factor rising to 29.1 and more than 2 million article downloads annually, we are constantly striving to be a cut above the rest!
🙏 Thank you to our Authors, Reviewers, and Readership for their continuous support of our journal.
#ImpactFactor #EurUrol #EAU #ACutAboveTheRest


























